Latest AJCC Edition Staging System May Not Be As Effective in Differentiating Survival in Melanoma

An external validation of the American Joint Committee on Cancer (AJCC) 8th edition staging system found that the latest edition maintained a similar prognostic accuracy as its predecessor

BMS’ Opdivo cuts risk of melanoma recurrence

Bristol-Myers Squibb’s Opdivo, which is being investigated as adjuvant treatment after surgery for stage IIIb/c or IV melanoma patients at high risk of recurrence, may significantly cut the risk of patients’ cancer returning at 24 months versus Yervoy.

Nivolumab More Effective Than Ipilimumab in Resected High-Risk Melanoma

Extended follow-up from the CheckMate 238 trial confirmed the superior efficacy of nivolumab compared with ipilimumab in patients with stage III and IV resected melanoma.

T-cell redirection therapy shows durable response for metastatic uveal melanoma

Immunocore Limited presented data from the IMCgp100-102 trial at the American Society of Clinical Oncology meeting that showed a durable response and strong overall survival rate in patients with metastatic uveal melanoma.

Cancer in the News

Feature Articles

New guidelines help some sufferers of melanoma avoid invasive treatment

Sweeping changes have been made to the guidelines used to diagnose and treat melanoma, reflecting the dramatic progress that has been made in the last decade.

Read the full story

Posted in Melanoma In The News, Information

ASCO 2018: PET imaging may top CT in predicting therapy response in melanoma patients

PET imaging may better predict long-term benefits and guide discontinuation of therapy compared to standard contrast CT for patients with metastatic melanoma, according to findings presented Monday, June 4, at the 2018 American Society of Clinical Oncology (ASC0) annual meeting in Chicago.

Read the full story

Posted in Melanoma In The News, Information

Combination therapy with SD-101, pembrolizumab shows promise for metastatic melanoma

Intralesional agent SD-101 plus pembrolizumab induced a high response rate with a tolerable safety profile among a small cohort of patients with metastatic melanoma, according to results of a phase 1b/phase 2 trial presented at ASCO Annual Meeting.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Blood test for deadly uveal cancer of the eye gives new hope to patients after ECU research

Uveal cancer is a particularly lethal from of the disease. In about half of all cases, the tumor will spread to other parts of a patient’s body.

Read the full story

Posted in Melanoma In The News, Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories